Differential Effects of Growth Hormone and Alfa Calcidol on Trabecular and Cortical Bones in Hypophysectomized Rats
暂无分享,去创建一个
[1] J. Aloia,et al. Synergistic Effect of Parathyroid Hormone and Growth Hormone on Trabecular and Cortical Bone Formation in Hypophysectomized Rats , 2010, Hormone Research in Paediatrics.
[2] J. Adams,et al. Back to the future: a new look at 'old' vitamin D. , 2008, The Journal of endocrinology.
[3] W. Jee,et al. Alfacalcidol-Stimulated Focal Bone Formation on the Cancellous Surface and Increased Bone Formation on the Periosteal Surface of the Lumbar Vertebrae of Adult Female Rats , 2008, Calcified Tissue International.
[4] J. Iwamoto,et al. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study. , 2007, Journal of nutritional science and vitaminology.
[5] J. Iwamoto,et al. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol. , 2006, Journal of nutritional science and vitaminology.
[6] J. Iwamoto,et al. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats. , 2006, Experimental animals.
[7] Alex J. Brown,et al. The vitamin D prodrugs 1α(OH)D2, 1α(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells , 2006 .
[8] J. Reginster,et al. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. , 2005, Journal of musculoskeletal & neuronal interactions.
[9] B. Tönshoff,et al. How safe is the treatment of uraemic children with recombinant human growth hormone? , 1991, Pediatric Nephrology.
[10] P. Midgley. Growth hormone therapy in children and adults , 2005 .
[11] R. Erben,et al. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats , 1992, Calcified Tissue International.
[12] D. Thompson,et al. Alfacalcidol restores cancellous bone in ovariectomized rats. , 2003, Journal of musculoskeletal & neuronal interactions.
[13] M. Bouxsein,et al. Osteoblast-specific Knockout of the Insulin-like Growth Factor (IGF) Receptor Gene Reveals an Essential Role of IGF Signaling in Bone Matrix Mineralization* , 2002, The Journal of Biological Chemistry.
[14] W. Blum,et al. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. , 2002, The Journal of clinical endocrinology and metabolism.
[15] E. Ogata,et al. Vitamin D Hormone Inhibits Osteoclastogenesis In Vivo by Decreasing the Pool of Osteoclast Precursors in Bone Marrow , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] H. Frost. Growth Hormone and Osteoporosis: An Overview of Endocrinological and Pharmacological Insights from the Utah Paradigm of Skeletal Physiology , 2004, Hormone Research in Paediatrics.
[17] S. Mohan,et al. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. , 2000, The Journal of clinical endocrinology and metabolism.
[18] L. Donahue,et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. , 2000, Endocrinology.
[19] W. Daughaday. Growth hormone axis overview – somatomedin hypothesis , 2000, Pediatric Nephrology.
[20] E. Ogata,et al. Alfacalcidol Inhibits Bone Resorption and Stimulates Formation in an Ovariectomized Rat Model of Osteoporosis: Distinct Actions from Estrogen , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] E. Ogata,et al. The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis , 1999, Calcified Tissue International.
[22] E. Schacht,et al. Rationale for Treatment of Involutional Osteoporosis in Women and for Prevention and Treatment of Corticosteroid-Induced Osteoporosis with Alfacalcidol , 1999, Calcified Tissue International.
[23] J. Aloia,et al. Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. , 1999, Bone.
[24] R. Erben,et al. Therapeutic Efficacy of 1α,25-Dihydroxyvitamin D3 and Calcium in Osteopenic Ovariectomized Rats: Evidence for a Direct Anabolic Effect of 1α,25-Dihydroxyvitamin D3 on Bone1 , 1998 .
[25] H. Burger,et al. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. , 1998, The Journal of clinical endocrinology and metabolism.
[26] J. Aloia,et al. Histologic evidence: Growth hormone completely prevents reduction in cortical bone gain and partially prevents cancellous osteopenia in the tibia of hypophysectomized rats , 1997, The Anatomical record.
[27] J. Aloia,et al. Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy. , 1997, The American journal of physiology.
[28] C. Higgins,et al. Normalization of ion transport in murine cystic fibrosis nasal epithelium using gene transfer. , 1997, The American journal of physiology.
[29] S. Wei,et al. Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency. , 1997, European journal of endocrinology.
[30] A. Freemont,et al. Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections. , 1996, Bone.
[31] R. Kumar,et al. Ontogeny of the 1,25‐dihydroxyvitamin D3 receptor in fetal rat bone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] R. Turner,et al. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. , 1995, Endocrinology.
[33] W. Goodman,et al. Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy. , 1995, Kidney international.
[34] J. Aloia,et al. Skeletal alterations in hypophysectomized rats: I. A histomorphometric study on tibial cancellous bone , 1995, The Anatomical record.
[35] J. Aloia,et al. Skeletal alterations in hypophysectomized rats: II. A histomorphometric study on tibial cortical bone , 1995, The Anatomical record.
[36] S. Mohan,et al. Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Hock,et al. Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone. , 1990, Endocrinology.
[38] E. Ritz,et al. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. , 1989, Kidney international.
[39] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] R. Gray,et al. Activation of renal 1,25-dihydroxyvitamin D3 synthesis by phosphate deprivation: evidence for a role for growth hormone. , 1985, Endocrinology.
[41] L. Forte,et al. Effects of hypophysectomy and growth hormone treatment on renal hydroxylation of 25-hydroxycholecalciferol in rats. , 1984, The Journal of endocrinology.
[42] R. Tsang,et al. Effects of growth hormone replacement therapy on 1,25-dihydroxyvitamin D and calcium metabolism. , 1983, The Journal of clinical endocrinology and metabolism.
[43] C. Langman,et al. 25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity. , 1982, The Journal of pediatrics.
[44] E. Spencer,et al. The mechanism of the action of growth hormone on vitamin D metabolism in the rat. , 1981, Endocrinology.